David R. Warren

Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity

Anita Mathias, Polina German, Bernard P. Murray et al. · Clinical Pharmacology & Therapeutics · 2009 · 208 citations

Medicine, Pharmacokinetics, Pharmacology +15

Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection

Calvin Cohen, Richard Elion, Peter Ruane et al. · AIDS · 2011 · 109 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Pharmacokinetics and Bioavailability of an Integrase and Novel Pharmacoenhancer-Containing Single-Tablet Fixed-Dose Combination Regimen for the Treatment of HIV

Polina German, David R. Warren, Steve West et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 93 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection

Richard Elion, Calvin Cohen, Joseph Gathe et al. · AIDS · 2011 · 92 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Linking community empowerment, decentralized governance, and public service provision through a local development framework

David R. Warren, Louis Helling, Rodrigo Lara Serrano · 2005 · 64 citations

Social Sciences, Development Studies, Public Governance +17